No Data
No Data
Cosel To Go Ex-Dividend On November 19th, 2024 With 27 JPY Dividend Per Share
November 18th (Japan Standard Time) - $Cosel(6905.JP)$ is trading ex-dividend on November 19th, 2024.Shareholders of record on November 20th, 2024 will receive 27 JPY dividend per share. The ex-
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
List of breakout stocks above the cloud in the market Code Stock name Closing price Leading Span A Leading Span B Tokyo Stock Exchange Prime Board <1515> Nittetsu Kogyo 4475 4316.25 4455 <1888> Wakuzuku Kensetsu363035033391 <2915> Kenko Mayo234522582134.5 <3073> DD Group12811276.51225 <3923> Laxus22312188.52000.
Cosel: Summary of financial results for the 1st quarter of the fiscal year ending 2025/5 [Japanese GAAP] (consolidated) (completion of mid-term review by certified public accountants, etc.)
List of stocks with cleared clouds (Part 2) [Ichimoku Kinko Hyo: List of Stocks with Cleared Clouds]
List of breakthrough stocks under the clouds Code Company Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1802> Obayashi Corporation 1807 1807.75 1825 <1860> TODA Corporation 986 994.5 1002 <2301> Gakujin Co., Ltd. 1663 1691.75 1715
Stocks that moved the previous day include INTLOOP, Management Solutions, and Eternal Hospitality Group, among others.
Stock name <Code> 17th closing price⇒Day-on-day comparison Cosel <6905> 1026 -144 Operating profit in the first quarter decreased by 72.0%. Hamee <3134> 1037 -94 Operating profit in the first quarter increased by 28.3%, but the progress rate towards the full-year financial estimates remains at 10.7%. Modalis <4883> 122 +30 The method of treating muscular dystrophy targeting the DMPK gene has been patented in Japan. INTLOOP <9556> 4080 +700 Operating profit for the fiscal year ending July 2025
Active and newly established stocks in the afternoon session.
*Cosel<6905> 1026 -144 First-quarter operating profit decreased by 72.0%. *Hamee<3134> 1037 -94 First-quarter operating profit increased by 28.3%, but the progress rate for the full-year forecast remains at 10.7%. *Modalis<4883> 122 +30 "Treatment method for muscular dystrophy targeting the DMPK gene" receives patent evaluation in Japan. *INTLOOP<9556> 4080 +700 25 July year operating profit expected to increase by 30.7% in the medium term.
No Data
No Data